Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Real-time Estimate Cboe BZX 02:19:31 2024-07-10 pm EDT 5-day change 1st Jan Change
28.2 USD +1.75% Intraday chart for Pfizer, Inc. +2.06% -1.81%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Pfizer: collaboration agreement with Evotec in France CF
Barclays Adjusts Pfizer's Price Target to $30 From $28 MT
Sector Update: Health Care Stocks Steady Premarket Wednesday MT
Evotec, Pfizer Enter Research Collaboration on Metabolic, Infectious Diseases MT
Evotec, Pfizer Team Up for Early Drug Discovery for Metabolic, infectious Diseases MT
Evotec with new recovery attempt - cooperation with Pfizer DP
PFIZER INC : JP Morgan gives a Neutral rating ZD
Evotec and Pfizer Collaborate to Advance Drug Discovery in France CI
Pfizer: succession open for scientific director CF
Pfizer Begins External Search for Chief Scientific Officer MT
Pfizer Chief Scientific Officer Mikael Dolsten Leaving DJ
Pfizer's longtime science chief Mikael Dolsten to step down RE
Pfizer Chief Scientific Officer Mikael Dolsten to step down RE
Pfizer Inc. Announces Resignation of Mikael Dolsten as Chief Scientific Officer and President CI
Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births RE
Rhythm Pharmaceuticals, Inc. Announces Appointment of Alastair Garfield, as Chief Scientific Officer CI
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code MT
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches MT
Pfizer: former State Street CEO joins board CF
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Management CI
PFIZER INC : Berenberg gives a Neutral rating ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount MT
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling MT
Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.72 USD
Average target price
32.01 USD
Spread / Average Target
+15.46%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Barclays Adjusts Pfizer's Price Target to $30 From $28